Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02751151 · ClinicalTrials.gov registry record · NA
Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients
A NA study, sponsored by Inova Health Care Services.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02751151 is a NA study that has completed, run by Inova Health Care Services. The registered enrollment target is 10 participants.
The verdict
NCT02751151, a NA study, has completed, sponsored by Inova Health Care Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The study will draw patients from the Transplant Dermatology specialty clinic, where the investigators see organ transplant recipients (OTR) for regular screening and serve as a regional referral center for this population. Enrollment will be limited to 20 patients. Inclusion criteria are organ transplant recipients status, active immunosuppression for at least 5 years, and history of at least one NMSC.
Interventions
- OTHER have Levulan Kerastick (aminolevulinic acid) solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-02 |
| Est. Completion | 2021-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02751151
The ClinicalTrials.gov registry entry for NCT02751151 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which have Levulan Kerastick (aminolevulinic acid) solution is the first listed.
NCT02751151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02751151 about?
NCT02751151 is a clinical study titled "Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients". The study will draw patients from the Transplant Dermatology specialty clinic, where the investigators see organ transplant recipients (OTR) for regular screening and serve as a regional referral center for this population. Enrollment will be limited to 20 patients. Inclusion criteria are organ tran...
What is the current status of trial NCT02751151?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-02. Estimated completion is 2021-05.
What interventions are being tested in trial NCT02751151?
The interventions under investigation include: have Levulan Kerastick (aminolevulinic acid) solution (OTHER).
Who is sponsoring clinical trial NCT02751151?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.